[1]
Lönndahl, L. et al. 2017. Substance P Antagonist Aprepitant Shows no Additive Effect Compared with Standardized Topical Treatment Alone in Patients with Atopic Dermatitis. Acta Dermato-Venereologica. 98, 3 (Dec. 2017), 324–328. DOI:https://doi.org/10.2340/00015555-2852.